Wayback Machine
Nov DEC Jan
Previous capture 19 Next capture
2014 2015 2016
1 captures
19 Dec 15 - 19 Dec 15
sparklines
Close Help
Skip to main content

Access brought to you by: LOCKSS

Login

MD Conference Express
Advanced Search

Main menu

  • HOME
  • BROWSE BY CONFERENCE
  • BROWSE BY DISCIPLINE
    • -- All Disciplines --
    • Anesthesiology
    • Cardiology & Cardiovascular Medicine
    • Dentistry
    • Dermatology
    • Endocrinology, Diabetes & Metabolism
    • Emergency Medicine & Critical Care
    • Hematology
    • Hepatology
    • Infectious Diseases
    • Nephrology
    • Neurology
    • Nutrition
    • Obstetrics & Gynecology
    • Oncology
    • Ophthalmology
    • Orthopaedics & Sports Medicine
    • Psychiatry & Psychology
    • Pulmonary & Respiratory Medicine
    • Radiology
    • Rheumatology
    • Veterinary Medicine
  • ABOUT
    • About Us
    • International Medical Advisory Board
    • Reprints
    • Librarian resources
    • Contact us
    • Help

progression-free survival

  • Veliparib Plus Platinum Therapy Promising in NSCLC Phase 2 Trial
  • LUX-Lung 5Afatinib Plus Paclitaxel Improves Outcomes for Metastatic NSCLC
  • Age-Stratified Subgroup Analysis of SQUIRE in Patients With Stage IV Squamous NSCLC
  • ALTER0302Anlotinib Increased PFS as Third-Line Treatment for Refractory Advanced NSCLC
  • ARCHER 1009 Subset Analysis and LUX-8 Lung: Erlotinib Compared With Dacomitinib or Afatinib
  • Gemcitabine Switch Maintenance Superior to Supportive Care in Advanced NSCLC
  • MRD and Clinical Response Predictors of PFS in CLL
  • Dasatinib Outcomes Maintained Over 5 Years
  • No Survival Benefit When Adding Everolimus to Trastuzumab and Paclitaxel in Advanced HER2-Positive BC
  • Results From the EPO-ANE-3010 Study Consistent With US Black Box Labeling

Other Products from SAGE / CQ Press

  • SAGE Journals
  • SAGE Knowledge
  • SAGE Research Methods
  • Help
Copyright © by SAGE Publications
Online ISSN: 1559-8977